Esaote North America Announces a NEW Addition to its Veterinary Ultrasound Portfolio

Esaote North America announces the addition of a new dedicated veterinary ultrasound product available for purchase in the USA, the MyLab™X75VET ultrasound system. The MyLab™X75VET is equipped with Esaote’s dedicated veterinary software and probes to address the demanding imaging needs of a wide range of veterinary applications.

This versatile console is ergonomically designed and offers premium cardiac imaging and an advanced measurement package. Additional features include:

  • Dedicated Veterinary software and probes – up to 22MHz
  • Workflow enhancements like easyMode, easyColor, and eScan
  • Optimized cardiac imaging
  • Integrated battery and Connectivity

Esaote North America is internationally recognized as a leader in providing superior Ultrasound solutions and Dedicated MRI systems. The latest portfolio of Ultrasound systems and MRI platforms are built on a Windows® 10 operating system for optimal security and equipped with advanced workflow enhancements to help users optimize workflow and increase efficiency.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version